Tag: GenDx
OSE Immunotherapeutics announces a collaboration agreement with GenDx for the development of a companion diagnostic test associated with Tedopi®, its epitope-based cancer vaccine candidate – 11/21/2023 at 6:00 p.m.
• A development program to support the next pivotal confirmatory phase 3 clinical trial currently being prepared.• A companion diagnostic test to identify HLA-A*02 positive cancer patients eligible for treatment…
OSE Immunotherapeutics enters into collaboration agreement with GenDx
By Alexandra Saintpierre Published on 11/21/2023 at 6:12 p.m. (Boursier.com) — OSE Immunotherapeutics SA announces a collaboration agreement…
Ose immuno: Collaboration agreement with GenDx
Read also (CercleFinance.com) – OSE Immunotherapeutics announces a collaboration agreement with GenDx (Eurobio Scientific Group) to develop and validate a companion diagnostic test (CDx) as part of the preparation of…
OSE Immuno: collaboration agreement with GenDx – 11/21/2023 at 6:09 p.m.
(CercleFinance.com) – OSE Immunotherapeutics announces a collaboration agreement with GenDx (Eurobio Scientific Group) to develop and validate a companion diagnostic test (CDx) as part of the preparation of the pivotal…
OSE Immunotherapeutics joins forces with GenDx for the clinical trial of its anti-cancer vascin – 11/21/2023 at 6:13 p.m.
(AOF) – OSE Immunotherapeutics announced a collaboration agreement with GenDx (Eurobio Scientific Group, a key player in the field of in vitro diagnostics). This will involve developing and validating a…
The acquisition of GenDx will create value for Eurobio Scientific
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? Sale ? What course objective? Our experts engage and…
Eurobio Scientific: acquires 100% of GenDx
(CercleFinance.com) – Eurobio Scientific announces the acquisition of 100% of the capital and voting rights of the Dutch company Genome Diagnostics BV (GenDx) from its founder and its shareholders for…
Eurobio Scientific: acquires 100% of GenDx – 03/10/2022 at 18:02
(CercleFinance.com) – Eurobio Scientific announces the acquisition of 100% of the capital and voting rights of the Dutch company Genome Diagnostics BV (GenDx) from its founder and its shareholders for…
Eurobio Scientific: towards the acquisition of GenDx for 135 ME – 08/17/2022 at 18:11
(CercleFinance.com) – Eurobio Scientific announces that it has signed an agreement today to acquire 100% of the capital and voting rights of the Dutch company Genome Diagnostics BV (GenDx) for…
Eurobio Scientific: towards the acquisition of GenDx for 135 ME
(CercleFinance.com) – Eurobio Scientific announces that it has signed an agreement today to acquire 100% of the capital and voting rights of the Dutch company Genome Diagnostics BV (GenDx) for…